No Data
Wanbangde Pharmaceutical Names CFO
Wanbangde Pharmaceutical Holding Group: The financial director, who served for only eight months, resigned, and the chairman once again acted as the director. | Quick Read Announcement
①Tonight, wanbangde pharmaceutical holding group announced that the Chief Financial Officer Wang Tianfang has resigned, having served in this position for only 8 months; ②Chairman Zhao Shouming once again assumes the responsibilities of the Chief Financial Officer, having temporarily served in this role when the former CFO Zhao Junhui resigned in June 2022; ③Within three years, wanbangde pharmaceutical holding group's market cap has shrunk to only one-third.
Concerns Surrounding Wanbangde Pharmaceutical Holding Group's (SZSE:002082) Performance
Wan Bond: 2024 Semi-Annual Report
Wan Bond: 2024 Semi-Annual Report Summary
wanbangde pharmaceutical holding group (002082.SZ) released its performance for the first half of the year, with a net income of 37.7041 million yuan, an increase of 19.36%.
Wanbangde Pharmaceutical Holding Group (002082.SZ) released its 2024 semi-annual report. During the reporting period, the company achieved revenue of 7...
Wanbangde Pharmaceutical Holding Group Co., Ltd. (SZSE:002082) Not Doing Enough For Some Investors As Its Shares Slump 28%No Data
No Data
